161 related articles for article (PubMed ID: 8428086)
1. Iron oxides as MR imaging contrast agents.
Fahlvik AK; Klaveness J; Stark DD
J Magn Reson Imaging; 1993; 3(1):187-94. PubMed ID: 8428086
[No Abstract] [Full Text] [Related]
2. Important considerations in the design of iron oxide nanoparticles as contrast agents for TI-weighted MRI and MRA.
Kellar KE; Fujii DK; Gunther WH; Briley-Saebø K; Bjornerod A; Spiller M; Koenig SH
Acad Radiol; 2002 May; 9 Suppl 1():S34-7. PubMed ID: 12019889
[No Abstract] [Full Text] [Related]
3. Three types of physical measurements needed to characterize iron oxide nanoparticles for MRI and MRA: magnetization, relaxometry, and light scattering.
Koenig SH; Kellar KE; Fujii DK; Gunther WH; Briley-Saebø K; Spiller M
Acad Radiol; 2002 May; 9 Suppl 1():S5-10. PubMed ID: 12019893
[No Abstract] [Full Text] [Related]
4. Target-specific superparamagnetic MR contrast agents.
Weissleder R
Magn Reson Med; 1991 Dec; 22(2):209-12; discussion 213-5. PubMed ID: 1812348
[No Abstract] [Full Text] [Related]
5. How can superparamagnetic iron oxides be used to monitor disease and treatment?
Unger EC
Radiology; 2003 Dec; 229(3):615-6. PubMed ID: 14657295
[No Abstract] [Full Text] [Related]
6. Superparamagnetic agents: physicochemical characteristics and preclinical imaging evaluation.
Benderbous S; Corot C; Jacobs P; Bonnemain B
Acad Radiol; 1996 Aug; 3 Suppl 2():S292-4. PubMed ID: 8796583
[No Abstract] [Full Text] [Related]
7. [Transmission electron microscopy in the structural study of superparamagnetic contrast agents for MRI].
Lucet I; Filmon R; Pouliquen D; Le Jeune JJ; Jallet P
Bull Assoc Anat (Nancy); 1994 Mar; 78(240):57-9. PubMed ID: 7519906
[TBL] [Abstract][Full Text] [Related]
8. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles.
Huang DM; Hsiao JK; Chen YC; Chien LY; Yao M; Chen YK; Ko BS; Hsu SC; Tai LA; Cheng HY; Wang SW; Yang CS; Chen YC
Biomaterials; 2009 Aug; 30(22):3645-51. PubMed ID: 19359036
[TBL] [Abstract][Full Text] [Related]
9. In situ analysis of a bimodal size distribution of superparamagnetic nanoparticles.
Thünemann AF; Rolf S; Knappe P; Weidner S
Anal Chem; 2009 Jan; 81(1):296-301. PubMed ID: 19117457
[TBL] [Abstract][Full Text] [Related]
10. Ferrimagnetic susceptibility contrast agents.
Bach-Gansmo T
Acta Radiol Suppl; 1993; 387():1-30. PubMed ID: 8390776
[TBL] [Abstract][Full Text] [Related]
11. Magnetic microparticle aggregation for viscosity determination by MR.
Hong R; Cima MJ; Weissleder R; Josephson L
Magn Reson Med; 2008 Mar; 59(3):515-20. PubMed ID: 18306403
[TBL] [Abstract][Full Text] [Related]
12. Frequency dependence of MR relaxation times. II. Iron oxides.
Bulte JW; Vymazal J; Brooks RA; Pierpaoli C; Frank JA
J Magn Reson Imaging; 1993; 3(4):641-8. PubMed ID: 8347958
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the contributions of diffusion and exchange in relaxation enhancement by MRI contrast agents.
Gossuin Y; Roch A; Muller RN; Gillis P
J Magn Reson; 2002; 158(1-2):36-42. PubMed ID: 12419669
[TBL] [Abstract][Full Text] [Related]
14. Preparation and quality test of superparamagnetic iron oxide labeled antisense oligodeoxynucleotide probe: a preliminary study.
Wen M; Li B; Ouyang Y; Luo Y; Li S
Ann Biomed Eng; 2009 Jun; 37(6):1240-50. PubMed ID: 19337837
[TBL] [Abstract][Full Text] [Related]
15. MR relaxivity measurement of iron oxide nano-particles for MR lymphography applications.
Firouznia K; Amirmohseni S; Guiti M; Amanpour S; Baitollahi A; Kharadmand AA; Mohagheghi MA; Oghabian MA
Pak J Biol Sci; 2008 Feb; 11(4):607-12. PubMed ID: 18817134
[TBL] [Abstract][Full Text] [Related]
16. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10.
Raynal I; Prigent P; Peyramaure S; Najid A; Rebuzzi C; Corot C
Invest Radiol; 2004 Jan; 39(1):56-63. PubMed ID: 14701989
[TBL] [Abstract][Full Text] [Related]
17. Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review.
Petersein J; Saini S; Weissleder R
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):53-60. PubMed ID: 8673716
[TBL] [Abstract][Full Text] [Related]
18. Basic physics of MR contrast agents and maximization of image contrast.
Hendrick RE; Haacke EM
J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
[TBL] [Abstract][Full Text] [Related]
19. Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging.
Frank JA; Anderson SA; Kalsih H; Jordan EK; Lewis BK; Yocum GT; Arbab AS
Cytotherapy; 2004; 6(6):621-5. PubMed ID: 15773025
[TBL] [Abstract][Full Text] [Related]
20. Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling.
Babic M; Horák D; Trchová M; Jendelová P; Glogarová K; Lesný P; Herynek V; Hájek M; Syková E
Bioconjug Chem; 2008 Mar; 19(3):740-50. PubMed ID: 18288791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
